Three major oncology organizations recommend that CEA be measured in patients with nonmetastatic colorectal cancer prior to surgical resection. In the current analysis, patients with a normal ...
Background: Carcinoembryonic antigen (CEA) is a widely used tumor marker for surveillance in colon cancer. However, its accuracy is still debatable as its levels vary based on several factors. Hence ...
This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results